AARD vs HBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

AARD

53.7
AI Score
VS
AARD Wins

HBIO

47.9
AI Score

Investment Advisor Scores

AARD

54score
Recommendation
HOLD

HBIO

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AARD HBIO Winner
Net Income -21.59M -56.70M AARD
Operating Income -22.46M -48.58M AARD
ROE -24.8% -412.8% AARD
ROA -21.9% -70.8% AARD
Total Assets 98.59M 80.07M AARD
Cash 62.44M 8.61M AARD
Current Ratio 8.06 2.20 AARD
Free Cash Flow -18.96M 5.47M HBIO

Relative Price Performance (Last 90 Days)

AARD 1M: +17.4% · 3M: +21.5% HBIO 1M: +0.8% · 3M: -4.4%

Current Technical Phase

AARD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.5% over 20 days), RSI 56

RSI (14): 56.2 · Price: $6.60

HBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $6.10

Fundamentals Snapshot

Metric AARD HBIO
Market Cap
Forward P/E -2.1 13.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.6%
Operating Margin 0.0% 0.0%
EPS -3.87 -2.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AARD is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.